CA
NZ
UK
AU
IND
US
JPMorgan Chase Financial Company LLC filed a free writing prospectus (FWP) fact sheet on November 9, 2026, disclosing terms for Market Linked Securities auto-callable with upside participation and contingent downside, linked to the lowest performing of the S&P 500 Index and the Nasdaq-100 Index, …
HA Sustainable Infrastructure Capital, Inc. filed an Issuer Free Writing Prospectus on November 9, 2026, disclosing pricing terms for a $500,000,000 offering of 7.850% Green Junior Subordinated Notes due 2057.
Booking Holdings Inc. filed a free writing prospectus on November 9, 2026, disclosing final pricing terms for four tranches of euro-denominated senior unsecured notes totaling €3,550,000,000 in aggregate principal amount, with settlement expected on November 13, 2026.
STERIS Irish FinCo Unlimited Company filed a free writing prospectus on November 9, 2026, disclosing the pricing terms for two tranches of senior notes totaling $1,500,000,000, with settlement expected on November 24, 2026.
The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC filed a joint Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of Class A ordinary shares of Alpex Acquisition Corporation as of September 30, 2026.
The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC filed an amended Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of common stock in People Incorporated as of September 30, 2026.
The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC filed an amended Schedule 13G with the SEC on October 8, 2026, disclosing beneficial ownership of approximately 4.3% of NETSTREIT Corp.'s common stock as of September 30, 2026.
The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC filed an amended beneficial ownership statement with the SEC on November 9, 2026, reporting zero beneficial ownership of ordinary shares of TNL Mediagene as of September 30, 2026.
The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC filed a joint Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of common stock in Pacific Biosciences of California, Inc. as of September 30, 2026.
The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC filed a joint Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of approximately 5.9% of Oxford Industries, Inc. common stock as of September 30, 2026.
Please wait processing your request...